Literature DB >> 18005924

Extra-skeletal Ewing's sarcoma of the submandibular gland.

Hakan Agir1, Helen D Brasch, Swee T Tan.   

Abstract

Extra-skeletal Ewing's sarcoma (EES) is an uncommon malignancy, especially in the head and neck region that may arise in various extra-osseous tissues. We report a 22-year-old male with an EES of the submandibular gland, which to the best of our knowledge, has not been described previously. The patient who underwent combined treatment with surgical resection and chemo-irradiation was disease free for 22 months but succumbed to multi-organ metastases 14 months later. This case highlights the combined diagnostic role of immunohistochemical, cytogenetic and radiological evaluation of EES. EES is an aggressive cancer that requires multidisciplinary management with wide surgical excision and adjunctive chemo-irradiation for the best outcome.

Entities:  

Mesh:

Year:  2006        PMID: 18005924     DOI: 10.1016/j.bjps.2006.01.046

Source DB:  PubMed          Journal:  J Plast Reconstr Aesthet Surg        ISSN: 1748-6815            Impact factor:   2.740


  4 in total

1.  The Rare Presentation of Extraskeletal Ewing's Sarcoma on the Forehead.

Authors:  Sung Hoon Choi; Young Joon Kim; Hoon Kim; Hyun-Jung Kim; Sang Hyun Nam; Young Woong Choi
Journal:  Arch Plast Surg       Date:  2015-01-14

2.  Ewing's sarcoma of the larynx. Effective treatment with organ preservation.

Authors:  A Wygoda; T Rutkowski; D Ponikiewska; B Hejduk; K Składowski
Journal:  Strahlenther Onkol       Date:  2013-06-05       Impact factor: 3.621

3.  Outcomes of the treatment of head and neck sarcomas in a tertiary referral center.

Authors:  Andrew Lindford; Benjamin McIntyre; Reginald Marsh; Craig A MacKinnon; Charles Davis; Swee T Tan
Journal:  Front Surg       Date:  2015-05-19

4.  Parotid Ewing's sarcoma: Extra-skeletal uncommon condition.

Authors:  Ayoub Sabr; Rachid Aloua; Ouassime Kerdoud; Faiçal Slimani
Journal:  Ann Med Surg (Lond)       Date:  2021-04-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.